Cargando…
Delayed Toxicity Associated with Soluble Anthrax Toxin Receptor Decoy-Ig Fusion Protein Treatment
Soluble receptor decoy inhibitors, including receptor-immunogloubulin (Ig) fusion proteins, have shown promise as candidate anthrax toxin therapeutics. These agents act by binding to the receptor-interaction site on the protective antigen (PA) toxin subunit, thereby blocking toxin binding to cell su...
Autores principales: | Thomas, Diane, Naughton, John, Cote, Christopher, Welkos, Susan, Manchester, Marianne, Young, John A. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325282/ https://www.ncbi.nlm.nih.gov/pubmed/22511955 http://dx.doi.org/10.1371/journal.pone.0034611 |
Ejemplares similares
-
Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination
por: Cote, Christopher K., et al.
Publicado: (2015) -
Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In Vivo
por: Scobie, Heather M, et al.
Publicado: (2006) -
Correction: Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In Vivo
por: Scobie, Heather M, et al.
Publicado: (2008) -
Tumor Endothelium Marker-8 Based Decoys Exhibit Superiority over Capillary Morphogenesis Protein-2 Based Decoys as Anthrax Toxin Inhibitors
por: Cai, Chenguang, et al.
Publicado: (2011) -
Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana
por: Karuppanan, Kalimuthu, et al.
Publicado: (2017)